By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic has signed a definitive agreement to acquire the genetic testing business of Clinical Data for approximately $15.4 million, the firms announced after the close of the market Monday.

The acquisition will provide Transgenomic with Clinical Data's portfolio of Familion genetic tests for cardiac syndromes and PGxPredict tests for predicting drug response, which are currently sold by its PGx Health division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.